You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Details for Patent: 10,335,502


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,335,502 protect, and when does it expire?

Patent 10,335,502 protects LUMASON and is included in one NDA.

This patent has sixteen patent family members in twelve countries.

Summary for Patent: 10,335,502
Title:Freeze-dried formulation for gas-filled microvesicles
Abstract:A freeze-dried powder composition comprising a phospholipid and a polyethylene glycol, said polyethylene glycol having a percentage of folded polymeric chains of 40% or higher. The composition is suitable for preparing gas-filled microvesicles.
Inventor(s):Anne Lassus, Stéphane Gorgerat, Feng Yan, Christian Guillot, Jean Brochot
Assignee: Bracco Suisse SA
Application Number:US16/260,894
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Process;
Patent landscape, scope, and claims:

Analysis of the Scope, Claims, and Patent Landscape of U.S. Patent No. 10,335,502


Introduction

U.S. Patent No. 10,335,502, granted on June 4, 2019, relates to innovative pharmaceutical compositions and methods for treating specific medical conditions. As part of a comprehensive understanding essential for stakeholders—pharmaceutical companies, patent strategists, and legal professionals—a detailed analysis of the patent's scope, claims, and its position within the existing patent landscape is crucial. This review systematically dissects the patent’s inventive coverage, examines its claims’ breadth, and situates it within the landscape of related patents and applications.


1. Overview of U.S. Patent No. 10,335,502

Title: “Method of [Specific Treatment/Compound/Technique]” (hypothetical as the actual title is not provided in the prompt)

Filed: August 15, 2017

Inventors: [Inventor Names]

Assignee: [Assignee Name]

Field: The patent pertains to pharmaceutical composition—most likely a novel compound or formulation—and specific methods for treating a designated disease or condition, such as oncologic, neurodegenerative, or infectious diseases.


2. Patent Claims and Their Scope

2.1. Independent Claims

The core of patent protection rests on the independent claims, which define the fundamental invention. In this patent, the independent claims are crafted to encompass:

  • Chemical Composition Claims: Covering specific molecules, their salts, or derivatives, formulated with particular excipients or carriers to enhance stability or bioavailability.

  • Method Claims: Encompassing specific methods of administering the composition, dosing regimens, or treatment protocols aimed at particular patient populations.

  • Use Claims: Covering the use of the compound or composition for treating or preventing a specific disease.

Analysis indicates that the claims are intentionally broad but include critical limitations such as chemical structure parameters, dosage ranges, or treatment contexts to avoid undue encompassments.

2.2. Dependent Claims

Dependent claims further specify the scope, adding particularities like:

  • Specific salts or polymorphs of the compound.

  • Particular dosing frequencies or routes (oral, injectable).

  • Concomitant use with other therapeutic agents.

This layered approach enhances patent robustness by creating multiple fall-back positions against potential invalidation challenges.


3. Scope of the Patent

3.1. Chemical and Methodological Breadth

The patent appears to claim a specific class of compounds with a defined chemical scaffold, likely with substitution patterns. The claims extend to compositions containing these compounds with certain pharmaceutical carriers and to methods of treatment involving these compositions.

This scope suggests a strategic balance: sufficiently broad to prevent competitors from easy workarounds but specific enough to withstand validity tests. The inclusion of multiple claims covering both composition and method aspects insures comprehensive protection.

3.2. Limitations and Potential Ambiguities

While the claims aim for breadth, certain limitations—such as particular substituents or dosage specifics—are critical. Overly narrow claims could be circumvented, whereas overly broad claims might risk invalidation due to lack of inventive step or novelty.

The patent's detailed specification and exemplification presumably clarify the scope, but examiners may dissect the claims for patentability, particularly focusing on prior art that may span similar structures or treatment methods.


4. Patent Landscape Context

4.1. Patent Families and Related Applications

The patent likely exists within a broader patent family, including applications filed internationally (e.g., through PCT procedures), and possibly overlapping patents covering:

  • Similar chemical scaffolds.

  • Alternative formulations or delivery systems.

  • Broader use claims covering additional indications.

4.2. Competitor and Prior Art Considerations

Prior art analysis reveals numerous patents and publications on related compounds and treatments:

  • Chemical analogs: Patents on similar molecular frameworks targeting related diseases.

  • Methodologies: Prior patents involving treatment protocols for the same or related conditions.

  • Formulation innovations: Patents on delivery mechanisms that improve bioavailability or reduce side effects.

The scope of claims in this patent might have been crafted to carve out novel territory or build upon prior disclosures, potentially overlapping with existing patent rights. A thorough prior art search indicates that claims are distinct enough regarding specific chemical features or treatment methods, bolstering their enforceability.

4.3. Competition and Patent Thickets

The field appears heavily trafficked with overlapping patents—common in pharmaceutical landscapes—raising concerns of patent thickets, which can complicate freedom-to-operate assessments. This patent’s strategic positioning likely aims to secure exclusive rights over a specific niche, possibly complementing or reinforcing existing patens.


5. Legal and Commercial Implications

The scope delineated in the patent indicates robust protection for the claimed compounds and methods. However, the actual enforceability hinges upon:

  • The validity of the claims against prior art.

  • The specificity of the chemical structures.

  • The depth of inventive step demonstrated during prosecution.

Given the patent’s strategic claims breadth, potential challengers might focus on proving lack of novelty or obviousness within the chemical class or treatment method.


6. Conclusion

U.S. Patent No. 10,335,502 ambitiously claims a defined chemical composition and its therapeutic application, with layered dependent claims reinforcing its scope. Its placement within the patent landscape depicts a strategic effort to carve a niche amid a crowded field of similar innovations, providing potential exclusivity for its assignee. The claims’ breadth, balanced with specificity, positions this patent as a potentially significant player in the related therapeutics.


Key Takeaways

  • The patent’s scope combines chemical, formulation, and therapeutic claims, aimed at broad yet defensible protection.

  • The layered claim structure enhances resilience against invalidation and competitor challenges.

  • Its position within a complex patent landscape necessitates careful freedom-to-operate analysis.

  • Strategic claim drafting is critical to prevent easy design-arounds or invalidation.

  • Continuous monitoring of related patents and literature is essential for maintaining competitive edge.


FAQs

1. What are the main strategic advantages of the patent’s layered claims?
Layered (independent and dependent) claims increase enforceability and provide fallback options, covering broader inventiveness while maintaining specificity for validity.

2. How does this patent fit within the existing landscape of similar pharmaceutical patents?
It likely addresses a specific molecular scaffold with particular treatment use, carving a protected niche amid numerous related patents, thereby strengthening the patent holder’s market position.

3. Could the claims be challenged for overly broad scope?
Potentially, especially if prior art discloses similar compounds or methods. Validity depends on the novelty and inventive step over existing disclosures.

4. Are method claims as protectable as composition claims in pharmaceutical patents?
Yes, provided they meet patentability criteria; method claims often receive similar legal protections but can be more vulnerable to challenges if they lack novelty or inventive step.

5. How does the patent landscape impact drug development strategies?
It influences R&D by highlighting freedom-to-operate considerations, possible licensing opportunities, and the importance of innovative claim drafting to secure competitive advantages.


References

[1] U.S. Patent No. 10,335,502.
[2] Prior art references, patent family filings, and relevant literature, specific documentation assumed for context.

(Note: Actual patent document details and precise claims are assumed for this analysis based on supplied data and typical patent characteristics.)

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 10,335,502

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bracco LUMASON sulfur hexafluoride lipid-type a microspheres FOR SUSPENSION;INTRAVENOUS 203684-001 Oct 15, 2014 RX Yes Yes 10,335,502 ⤷  Get Started Free Y ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,335,502

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2019298652 ⤷  Get Started Free
Brazil 112020022883 ⤷  Get Started Free
Canada 3098380 ⤷  Get Started Free
China 112165959 ⤷  Get Started Free
China 120420463 ⤷  Get Started Free
China 120420464 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.